# Laser Treatment for Onychomycosis in Diabetes

> **NCT02019446** · NA · UNKNOWN · sponsor: **BCDiabetes.Ca** · enrollment: 60 (estimated)

## Conditions studied

- Diabetes Mellitus, Type 2
- Onychomycosis

## Interventions

- **DEVICE:** Laser Treatment YAG laser
- **DRUG:** Standard Treatment (control group) terbinafine hydrochloride tablets

## Key facts

- **NCT ID:** NCT02019446
- **Lead sponsor:** BCDiabetes.Ca
- **Sponsor class:** NETWORK
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-07
- **Primary completion:** 2020-12
- **Final completion:** 2021-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2017-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02019446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02019446, "Laser Treatment for Onychomycosis in Diabetes". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02019446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*